The use of systemic corticosteroids in debilitating sycosis barbae, sycosis barbae fulminans.

Submitted as: (mark with X) X_Case Report _Case Presentation _Photo Vignette _Letter Authors declare that the contents of this article are their own original unpublished findings. Title: The use of systemic corticosteroids in debilitating sycosis barbae, sycosis barbae fulminans Authors: Kathleen R Krivda MD, Uzoamaka J Okoro MD, Nicholas F Logemann DO Affiliations: Department of Dermatology, Walter Reed National Military Medical Center, Bethesda, Bethesda, Maryland, USA Corresponding Author: Kathleen Krivda MD, Walter Reed National Military Medical Center, 8901 Rockville Pike, Bethesda MD 20889, Tel: 240-751-3823, Email: kathleenkrivda@gmail.com Abstract (no more than 200 words).

The Burden of Skin Cancer in the Military Health System, 2017-2022.

This retrospective observational study investigates skin cancer prevalence and care patterns within the Military Health System (MHS) from 2017 to 2022. Utilizing the MHS Management Analysis and Reporting Tool (most commonly called M2), we analyzed more than 5 million patient encounters and documented skin cancer prevalence in the MHS beneficiary population utilizing available demographic data. Notable findings included an increased prevalence of skin cancer in the military population compared with the civilian population, a substantial decline in direct care (DC) visits at military treatment facilities compared with civilian purchased care (PC) visits, and a decreased total number of visits during COVID-19 restrictions.